Sotera Health Q2 Earnings Preview: Revenue Expectations Flat YoY

Sotera Health Company is set to report Q2 earnings on Friday. Analysts expect revenue to be flat YoY at $275.6 million and adjusted earnings of $0.17 per share. The company has missed revenue estimates twice in the last two years. Sotera Health has underperformed the research tools & consumables group, which has seen share prices down 5.7% on average over the last month. The average analyst price target for Sotera Health is $14.58, compared to its current share price of $11.06.

Sotera Health Company (SHC), a provider of mission-critical sterilization, lab testing, and advisory services, is set to release its Q2 2025 earnings report on Friday. Analysts expect the company to report revenue of $275.6 million, flat year over year (YoY), and adjusted earnings per share (EPS) of $0.17. The company has faced challenges in the past, having missed revenue estimates twice in the last two years [1].

The research tools and consumables group, which includes competitors like Mettler-Toledo and Thermo Fisher, has seen an average share price decline of 5.7% over the past month. Despite this, Sotera Health has underperformed, with its stock down 4.6% during the same period [1]. The average analyst price target for Sotera Health is $14.58, compared to its current share price of $11.06 [1].

KeyBanc Capital recently upgraded Sotera Health to an overweight rating, indicating a positive outlook on the company's prospects [2]. However, the company's stock has been volatile, with significant fluctuations in price and analyst ratings over the past few years [2].

Investors will be closely watching Sotera Health's earnings report to gauge the company's performance and growth prospects. The company's ability to maintain its market position and adapt to industry challenges will be crucial in determining its future success.

References:
[1] https://finance.yahoo.com/news/sotera-health-company-shc-q2-030137521.html
[2] https://www.marketwatch.com/investing/stock/shc